← Open Payments lookup

ERIN HARRELL: Open Payments

NPI 1497123343 · HERNANDO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,253 in 75 payments from 12 companies in 2025. Trend: 2023 $2,024 · 2024 $1,489 · 2025 $1,253

Food & beverage: $1,253
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$227
ABBVIE INC.18$202
Collegium Pharmaceutical, Inc.12$165
Neurocrine BioSciences, Inc.10$163
Supernus Pharmaceuticals, Inc.9$158
Axsome Therapeutics, Inc.4$102
Otsuka America Pharmaceutical, Inc.3$74
Alkermes, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.3$59
Vanda Pharmaceuticals Inc.1$26

Products named: CAPLYTA, VRAYLAR, Jornay PM, INGREZZA, Qelbree, Auvelity, ARISTADA, TRINTELLIX.

Industry payments across MS — which companies pay providers there.